Price : USD 65.00

Description:

Aromasin (chemical name: exemestane) is an aromatase inhibitor approved by the U.S. Food and Drug Administration (FDA) to treat: postmenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer after they've taken tamoxifen for 2 to 3 years to reduce the risk of the cancer coming back.

Terms & conditions:

Search Website

Search

Subscribe

Newsletter

WhatsApp Google Map

Safety and Abuse Reporting

Thanks for being awesome!

We appreciate you contacting us. Our support will get back in touch with you soon!

Have a great day!

Are you sure you want to report abuse against this website?

Please note that your query will be processed only if we find it relevant. Rest all requests will be ignored. If you need help with the website, please login to your dashboard and connect to support